Kaneka

Flow Chemistry

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Flow Chemistry

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Interview: Alan Walker, Kaneka

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

Kaneka Buys Spanish Biotech

Kaneka Aerospace Takes Henkel’s Composites

Kaneka Expands Belgian Foams Plant

Kaneka Completes Takeover of BASF’s PVC Additives

BASF to Sell PVC Modifiers Business to Kaneka